“Maximal” drug therapy is not necessarily optimal in chronic angina pectoris
- 1 April 1984
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 3 (4) , 1051-1057
- https://doi.org/10.1016/s0735-1097(84)80366-6
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Calcium-channel blockers and beta blockers: Advantages and disadvantages of combination therapy in chronic stable angina pectorisAmerican Heart Journal, 1982
- Nifedipine and propranolol: A beneficial drug interactionThe American Journal of Medicine, 1981
- Reassessment of vasodilator therapy in angina: Effects of oral isosorbide dinitrate and hydralazine on exercise tolerance in patients receiving propranololThe American Journal of Cardiology, 1981
- Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical ApplicationsAnnals of Internal Medicine, 1980
- Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy.Circulation, 1980
- Combined High-Dosage Administration of Nifedipine and Propranolol in Patients with Angina PectorisClinical Science, 1980
- Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectorisThe American Journal of Cardiology, 1979
- Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris.Circulation, 1975
- Dose response effectiveness of propranolol for the treatment of angina pectoris.Circulation, 1975
- Propranolol and isosorbide dinitrate synergism in angina pectorisThe American Journal of Cardiology, 1968